English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
腾讯网
11 天
信达生物PD-1/IL-2α靶向抗体完成首个关键注册临床研究首例受试者给药
经济观察网讯 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Senate passes funding bill
Sworn in as Canada's PM
Second protester arrested
Texas measles outbreak
Influencer leaves Australia
Massive dust storms in Texas
Visits DOJ for speech
Plane engine catches fire
Man hit by motorcade, dies
Consumer sentiment drops
Permanently shuts route
SpaceX launches Crew-10
Court lifts Trump's DEI block
Gold rises to new heights
Laceration hazard recall
Trump Tower protest
Strikes deal with DOGE
Hamas to release hostage
Smishing scam warning
FDA, NIH nominees advance
Swatting call about gunman
To cut 2,000+ jobs
$3B deal to extend rights
‘Ted Lasso’ is coming back
Influential WY senator dies
Senate confirmation hearing
Top FDA lawyer resigns
Pleads not guilty
To host Golden Globes
Coffee creamer recall
UN report accuses Israel
March megastorm
Legendary sportswriter dies
Wins longest-ever Iditarod
Top intelligence agency visit
反馈